Literature DB >> 19046196

Prevalence and incidence of Type 2 diabetes and its complications 1996-2003--estimates from a Swedish population-based study.

A Ringborg1, P Lindgren, M Martinell, D D Yin, S Schön, J Stålhammar.   

Abstract

AIMS: To determine the prevalence and incidence of Type 2 diabetes and its complications in Uppsala county, Sweden between 1996 and 2003.
METHODS: Retrospective population-based study of patients with Type 2 diabetes identified in computerized medical records at 26 county primary care centres. Prevalence and incidence of Type 2 diabetes were estimated in the population aged 30-39, 40-49, 50-59, 60-69, 70-79 and > or = 80 years. Mortality, prevalence and incidence of complications in patients with Type 2 diabetes were determined through linkage to national inpatient, uraemia and cause-of-death registers.
RESULTS: Crude prevalence of Type 2 diabetes increased from 2.2 to 3.5% between 1996 and 2003. In the population aged > or = 30 years, the age- and sex-adjusted period increase was 53%[odds ratio (OR) 1.53, 95% confidence interval (CI) 1.47-1.58]. Crude population incidence was approximately stable after 1997 (3.7 cases/1000 residents in 1997 compared with 3.8/1000 in 2003). Age- and sex-adjusted mortality rates in Type 2 diabetic patients decreased by 4% per year (OR 0.96, 95% CI 0.94-0.97). Prevalence rates of cardiovascular disease in Type 2 diabetic patients were essentially stable, affecting 13.8% of females and 18.0% of males in 2003. No trend was detected for prevalence of renal failure or incidence of acute myocardial infarction, stroke and amputation.
CONCLUSIONS: Prevalence of Type 2 diabetes increased in Uppsala county between 1996 and 2003 as a consequence of approximately stable incidence since 1997 and declining mortality. Rates of diabetes-related complications, notably cardiovascular disease, continued to impose a substantial burden.

Entities:  

Mesh:

Year:  2008        PMID: 19046196     DOI: 10.1111/j.1464-5491.2008.02541.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  20 in total

Review 1.  [Diabetic maculopathy and retinopathy. Functional and sociomedical significance].

Authors:  J G Garweg; A Wenzel
Journal:  Ophthalmologe       Date:  2010-07       Impact factor: 1.059

Review 2.  Global trends in diabetes complications: a review of current evidence.

Authors:  Jessica L Harding; Meda E Pavkov; Dianna J Magliano; Jonathan E Shaw; Edward W Gregg
Journal:  Diabetologia       Date:  2018-08-31       Impact factor: 10.122

3.  Reduced incidence of lower-extremity amputations in people with diabetes in Scotland: a nationwide study.

Authors:  Brian Kennon; Graham P Leese; Lynda Cochrane; Helen Colhoun; Sarah Wild; Duncan Stang; Naveed Sattar; Donald Pearson; Robert S Lindsay; Andrew D Morris; Shona Livingstone; Matthew Young; John McKnight; Scott Cunningham
Journal:  Diabetes Care       Date:  2012-09-25       Impact factor: 19.112

4.  Is thiazolidinediones use a factor in delaying the need for insulin therapy in type 2 patients with diabetes? A population-based cohort study.

Authors:  Greg A Carney; Ken Bassett; James M Wright; Colin R Dormuth
Journal:  BMJ Open       Date:  2012-11-12       Impact factor: 2.692

5.  Risk management in the treatment of type 2 diabetes with pioglitazone.

Authors:  Giuseppe Derosa; Sibilla At Salvadeo
Journal:  Diabetes Metab Syndr Obes       Date:  2009-07-01       Impact factor: 3.168

6.  Risk of cancer following hospitalization for type 2 diabetes.

Authors:  Kari Hemminki; Xinjun Li; Jan Sundquist; Kristina Sundquist
Journal:  Oncologist       Date:  2010-05-17

7.  Automated data extraction--a feasible way to construct patient registers of primary care utilization.

Authors:  Mats Martinell; Jan Stålhammar; Johan Hallqvist
Journal:  Ups J Med Sci       Date:  2012-03       Impact factor: 2.384

8.  Effects of losartan vs candesartan in reducing cardiovascular events in the primary treatment of hypertension.

Authors:  S E Kjeldsen; J Stålhammar; P Hasvold; J Bodegard; U Olsson; D Russell
Journal:  J Hum Hypertens       Date:  2009-11-05       Impact factor: 3.012

9.  Familial risks for type 2 diabetes in Sweden.

Authors:  Kari Hemminki; Xinjun Li; Kristina Sundquist; Jan Sundquist
Journal:  Diabetes Care       Date:  2009-11-10       Impact factor: 19.112

10.  The risk of type 2 diabetes in men is synergistically affected by parental history of diabetes and overweight.

Authors:  Cecilia Wikner; Bruna Gigante; Mai-Lis Hellénius; Ulf de Faire; Karin Leander
Journal:  PLoS One       Date:  2013-04-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.